Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports

Quizartinib is a tyrosine kinase inhibitor selectively targeting the FMS-like tyrosine kinase 3 (FLT3) receptor that has been developed for the treatment of acute myeloid leukaemia (AML). The Phase 3 QuANTUM-R study investigated the efficacy of quizartinib monotherapy in patients with relapsed/refra...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Drug Investig
Main Authors: Martínez-Cuadrón, David, Rodríguez-Macías, Gabriela, Rodríguez-Veiga, Rebeca, Boluda, Blanca, Montesinos, Pau
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2020
Fag:
Practical Application
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035240/
https://ncbi.nlm.nih.gov/pubmed/31912423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-019-00881-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker